We are driven by our mission to deliver superior care.
That means more than just treating symptoms.
At every stage, we proactively strive to improve quality of life by identifying, managing, and ultimately limiting the progression of chronic kidney disease. We believe in engaging the patient as a partner in their welfare. With this patient-centered approach, we enlist providers to deliver the highest quality of coordinated care. And finally, we’re committed to the continuous discovery and deployment of the absolute best-practices available in the industry — in clinical methodology and patient service alike.
New Jersey Kidney Care has partnered with Frenova Renal Research to become a Clinical Research Managed Site. Frenova, a Fresenius Medical Care North America company, is the only clinical development partner dedicated exclusively to renal research through End Stage Renal Disease (ESRD) studies and Chronic Kidney Disease (CKD) studies within its network of high-volume, preferred research sites such as New Jersey Kidney Care. Frenova is committed to improving the quality of outcomes in ESRD and CKD studies to ultimately impact the course of disease progression in the community.
New Jersey Kidney Care has been awarded the American Heart Association’s Hypertension Practice Center Certification to recognize the practice’s commitment to following research-based-treatment guidelines to care for people with complex or difficult-to-treat hypertension, or high blood pressure.
New Jersey Kidney Care is the only certified hypertension practice in North New Jersey and the entire metro area. We are thoroughly committed to providing our patients the highest quality hypertension care centered in current scientific research.
